Herbalife Ltd HLF
12.55
0.34
2.78%
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 7.8×
Follow HLF
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
2.67 | 5.78 | 6.32 | 8.22 |
P/S ratio |
0.18 | 0.26 | 0.30 | 0.26 | |
P/FCF ratio |
4.02 | 5.24 | 4.09 | 4.26 | |
P/Operating CF |
6.28 | 13.48 | 13.43 | 41.77 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.52 | 0.59 | 0.60 | 0.58 | |
EV/EBITDA |
4.25 | 4.92 | 4.98 | 4.92 | |
EV/Operating CF |
8.48 | 8.89 | 6.86 | 7.87 | |
EV/FCF |
11.91 | 11.72 | 8.21 | 9.37 | |
Quick Ratio |
0.40 | 0.44 | 0.55 | 0.50 | |
Current Ratio |
1.11 | 1.13 | 1.23 | 1.20 | |
Net Debt/EBITDA |
10.94 | 12.70 | 9.18 | 10.30 | |
Debt/Assets |
74.81% | 71.52% | 69.25% | 70.54% | |
Debt/Equity |
(3.33) | (3.91) | (4.59) | (4.32) | |
Asset Turnover |
1.85 | 1.83 | 1.85 | 1.86 | |
Operating CF/Net income |
3.21 | 1.15 | 1.84 | (1.25) | |
Capex/Depreciation |
(0.68) | (0.63) | (0.37) | (0.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
67.81% | 69.75% | 67.81% | 68.00% | |
Intangible Assets out of Total Assets |
0.15 | 0.15 | 0.14 | 0.16 | |
Share Based Compensation of Revenue |
0.88% | 0.85% | 0.80% | 0.76% | |
Graham Net Nets |
(2.52) | (1.62) | (1.35) | (1.57) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
37.44% | 17.30% | 15.83% | 12.17% | |
Free Cash Flow Yield |
24.89% | 19.09% | 24.47% | 23.45% | |
Revenue per Share |
12.33 | 12.48 | 12.69 | 12.70 | |
Operating CF per Share |
1.34 | 0.96 | 1.10 | 0.31 | |
Capex per Share |
(0.20) | (0.18) | (0.10) | (0.11) | |
Free Cash Flow per Share |
1.14 | 0.78 | 0.99 | 0.21 | |
Cash per Share |
2.96 | 3.43 | 4.35 | 3.55 | |
Shareholders Equity per Share |
(5.87) | (4.96) | (4.18) | (4.47) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(5.87) | (4.96) | (4.18) | (4.47) | |
Free Cash Flow |
118.00 | 79.80 | 102.90 | 21.60 | |
Working Capital |
106.30 | 131.80 | 230.00 | 195.30 | |
Capital Expenditures |
(20.80) | (18.50) | (10.90) | (11.30) | |
Net Current Asset Value |
(2,197.00) | (2,150.60) | (2,057.30) | (2,155.80) | |
EV/EBIT |
5.30 | 6.16 | 6.18 | 6.13 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
3.39% | 6.66% | 4.70% | (1.98%) | |
Price to Operating Income |
1.79 | 2.75 | 3.08 | 2.79 | |
| Other line items | |||||
Average Receivables |
89.90 | 80.40 | 98.05 | 106.05 | |
Average Payables |
87.35 | 84.90 | 86.75 | 96.55 | |
Average Inventory |
513.90 | 493.55 | 491.30 | 510.40 | |
Average Assets |
2,675.35 | 2,757.00 | 2,779.75 | 2,796.90 | |
Average Common Equity |
(780.10) | (655.25) | (585.10) | (560.65) |
Columns are period end dates